TrialAnnals of oncology : official journal of the European Society for Medical Oncology2019

Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer.

E J Small et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.